Advertisement
Canada markets close in 4 hours 28 minutes
  • S&P/TSX

    22,323.61
    +64.14 (+0.29%)
     
  • S&P 500

    5,194.90
    +14.16 (+0.27%)
     
  • DOW

    38,935.96
    +83.69 (+0.22%)
     
  • CAD/USD

    0.7299
    -0.0022 (-0.31%)
     
  • CRUDE OIL

    78.23
    -0.25 (-0.32%)
     
  • Bitcoin CAD

    87,525.71
    +690.17 (+0.79%)
     
  • CMC Crypto 200

    1,323.39
    -41.74 (-3.06%)
     
  • GOLD FUTURES

    2,324.60
    -6.60 (-0.28%)
     
  • RUSSELL 2000

    2,075.82
    +15.15 (+0.74%)
     
  • 10-Yr Bond

    4.4290
    -0.0600 (-1.34%)
     
  • NASDAQ

    16,378.00
    +28.76 (+0.18%)
     
  • VOLATILITY

    13.51
    +0.02 (+0.15%)
     
  • FTSE

    8,317.17
    +103.68 (+1.26%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6771
    -0.0021 (-0.31%)
     

Analysts’ Recommendations for Novartis on April 17

Analysts’ Recommendations for Novartis on April 17

Novartis AG (NVS) reported revenue of $12.9 billion and EPS (earnings per share) of $1.21 in 4Q17, a 4.8% rise in revenue compared to 4Q16. For 1Q18, analysts expect Novartis to see EPS of $1.28 on revenue of $12.6 billion.